Cargando…

Tissue Viability of Free Flaps after Extracorporeal Perfusion Using a Modified Hydroxyethyl Starch Solution

Background: In free flap surgery, tissue is stored under hypothermic ischemia. Extracorporeal perfusion (EP) has the potential to extend storage time and the tissue’s perspective of survival. In the present study, the aim is to improve a recently established, simplified extracorporeal perfusion syst...

Descripción completa

Detalles Bibliográficos
Autores principales: Taeger, Christian D., Friedrich, Oliver, Horch, Raymund E., Distler, Caroline, Kengelbach-Weigand, Annika, Wenzel, Carina, Prantl, Lukas, Präbst, Konstantin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761798/
https://www.ncbi.nlm.nih.gov/pubmed/33287393
http://dx.doi.org/10.3390/jcm9123929
_version_ 1783627652598333440
author Taeger, Christian D.
Friedrich, Oliver
Horch, Raymund E.
Distler, Caroline
Kengelbach-Weigand, Annika
Wenzel, Carina
Prantl, Lukas
Präbst, Konstantin
author_facet Taeger, Christian D.
Friedrich, Oliver
Horch, Raymund E.
Distler, Caroline
Kengelbach-Weigand, Annika
Wenzel, Carina
Prantl, Lukas
Präbst, Konstantin
author_sort Taeger, Christian D.
collection PubMed
description Background: In free flap surgery, tissue is stored under hypothermic ischemia. Extracorporeal perfusion (EP) has the potential to extend storage time and the tissue’s perspective of survival. In the present study, the aim is to improve a recently established, simplified extracorporeal perfusion system. Methods: Porcine musculus rectus abdominis were stored under different conditions. One group was perfused continuously with a simplified one-way perfusion system for six hours, while the other received only a single flush but no further treatment. A modified hydroxyethyl starch solution was used as a perfusion and flushing solution. Vitality, functionality, and metabolic activity of both groups were analyzed. Results: Perfused muscles, in contrast to the ischemically stored ones, showed no loss of vitality and significantly less functionality loss, confirming the superiority of storage under continuous perfusion over ischemic storage. Furthermore, in comparison to a previous study, the results were improved even further by using a modified hydroxyethyl starch solution. Conclusion: The use of EP has major benefits compared to the clinical standard static storage at room temperature. Continuous perfusion not only maintains the oxygen and nutrient supply but also removes toxic metabolites formed due to inadequate storage conditions.
format Online
Article
Text
id pubmed-7761798
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-77617982020-12-26 Tissue Viability of Free Flaps after Extracorporeal Perfusion Using a Modified Hydroxyethyl Starch Solution Taeger, Christian D. Friedrich, Oliver Horch, Raymund E. Distler, Caroline Kengelbach-Weigand, Annika Wenzel, Carina Prantl, Lukas Präbst, Konstantin J Clin Med Article Background: In free flap surgery, tissue is stored under hypothermic ischemia. Extracorporeal perfusion (EP) has the potential to extend storage time and the tissue’s perspective of survival. In the present study, the aim is to improve a recently established, simplified extracorporeal perfusion system. Methods: Porcine musculus rectus abdominis were stored under different conditions. One group was perfused continuously with a simplified one-way perfusion system for six hours, while the other received only a single flush but no further treatment. A modified hydroxyethyl starch solution was used as a perfusion and flushing solution. Vitality, functionality, and metabolic activity of both groups were analyzed. Results: Perfused muscles, in contrast to the ischemically stored ones, showed no loss of vitality and significantly less functionality loss, confirming the superiority of storage under continuous perfusion over ischemic storage. Furthermore, in comparison to a previous study, the results were improved even further by using a modified hydroxyethyl starch solution. Conclusion: The use of EP has major benefits compared to the clinical standard static storage at room temperature. Continuous perfusion not only maintains the oxygen and nutrient supply but also removes toxic metabolites formed due to inadequate storage conditions. MDPI 2020-12-03 /pmc/articles/PMC7761798/ /pubmed/33287393 http://dx.doi.org/10.3390/jcm9123929 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Taeger, Christian D.
Friedrich, Oliver
Horch, Raymund E.
Distler, Caroline
Kengelbach-Weigand, Annika
Wenzel, Carina
Prantl, Lukas
Präbst, Konstantin
Tissue Viability of Free Flaps after Extracorporeal Perfusion Using a Modified Hydroxyethyl Starch Solution
title Tissue Viability of Free Flaps after Extracorporeal Perfusion Using a Modified Hydroxyethyl Starch Solution
title_full Tissue Viability of Free Flaps after Extracorporeal Perfusion Using a Modified Hydroxyethyl Starch Solution
title_fullStr Tissue Viability of Free Flaps after Extracorporeal Perfusion Using a Modified Hydroxyethyl Starch Solution
title_full_unstemmed Tissue Viability of Free Flaps after Extracorporeal Perfusion Using a Modified Hydroxyethyl Starch Solution
title_short Tissue Viability of Free Flaps after Extracorporeal Perfusion Using a Modified Hydroxyethyl Starch Solution
title_sort tissue viability of free flaps after extracorporeal perfusion using a modified hydroxyethyl starch solution
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761798/
https://www.ncbi.nlm.nih.gov/pubmed/33287393
http://dx.doi.org/10.3390/jcm9123929
work_keys_str_mv AT taegerchristiand tissueviabilityoffreeflapsafterextracorporealperfusionusingamodifiedhydroxyethylstarchsolution
AT friedricholiver tissueviabilityoffreeflapsafterextracorporealperfusionusingamodifiedhydroxyethylstarchsolution
AT horchraymunde tissueviabilityoffreeflapsafterextracorporealperfusionusingamodifiedhydroxyethylstarchsolution
AT distlercaroline tissueviabilityoffreeflapsafterextracorporealperfusionusingamodifiedhydroxyethylstarchsolution
AT kengelbachweigandannika tissueviabilityoffreeflapsafterextracorporealperfusionusingamodifiedhydroxyethylstarchsolution
AT wenzelcarina tissueviabilityoffreeflapsafterextracorporealperfusionusingamodifiedhydroxyethylstarchsolution
AT prantllukas tissueviabilityoffreeflapsafterextracorporealperfusionusingamodifiedhydroxyethylstarchsolution
AT prabstkonstantin tissueviabilityoffreeflapsafterextracorporealperfusionusingamodifiedhydroxyethylstarchsolution